Newsroom
Sorted by: Latest
-
IonQ Publishes World’s First Fully Compiled, End-to-End Blueprint for Breaking 256-Bit Elliptic-Curve Signatures
COLLEGE PARK, Md.--(BUSINESS WIRE)--IonQ (NYSE: IONQ), the world’s leading full-stack quantum platform and foundry, today published the first complete, end-to-end fault-tolerant resource estimate for running Shor’s algorithm. The historic paper by IonQ’s research team uses the recently published Walking Cat architecture to demonstrate how a specific application can be optimized for a trapped-ion quantum computer. This work concludes that a 20,000-physical-qubit IonQ quantum computer is expected...
-
Marcus Theatres Sets More Records with Highest Summer Revenue of All Time
MILWAUKEE--(BUSINESS WIRE)--Marcus Theatres®, the nation’s fourth largest theatre circuit and a division of Marcus Corporation (NYSE: MCS), announced today that it recorded its highest total revenue for the summer moviegoing season in company history, defined as the first Friday in May through Labor Day. Fueled by blockbuster hits and a diverse slate of summer releases that appealed to a wide range of audiences, summer records set at Marcus Theatres include: Highest total summer revenue in comp...
-
GAMCO Investors UK Regulatory Announcement: Form 8.3
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: GAMCO Investors, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. ...
-
Faeth Therapeutics to Host Virtual KOL Event on Multi-Nodal Inhibition for the Treatment of Endometrial Cancer on October 6, 2026
AUSTIN, Texas--(BUSINESS WIRE)--Faeth Therapeutics (Nasdaq: FTH), a clinical-stage oncology company developing multi-node therapies for cancer patients, including its lead program PIKTOR, today announced that it will host a virtual key opinion leader (KOL) event on Tuesday, October 6, 2026 at 10:00 AM ET featuring Marcus Goncalves, MD, PhD (NYU Langone Health & Scientific Co-founder, Faeth Therapeutics), who will join company management to discuss the PAM (PI3K/AKT/mTOR) pathway in human can...
-
Verastem Oncology to Unveil New Clinical Data Highlighting the Best-in-Class Potential of VS-7375, an Oral KRAS G12D (ON/OFF) Inhibitor, Across Pancreatic, Lung, and Colorectal Cancers
BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced it will host an investor event on Wednesday, October 14, at 8:00 am ET to present initial efficacy and updated safety and tolerability data for VS-7375 in pancreatic, lung, and colorectal cancers from the ongoing TARGET-D clinical development program. The upcoming presentation will build on the clinical upd...
-
Best’s Special Report: U.S. Property/Casualty Industry Nearly Tripled Net Underwriting Income in First-Half 2026
OLDWICK, N.J.--(BUSINESS WIRE)--The U.S. property/casualty (P/C) industry recorded $31.2 billion in net underwriting income in the first half of 2026, nearly three times the $10.9 billion posted in the same prior-year period, according to a new AM Best report. These preliminary results are detailed in a new Best’s Special Report, titled, “First Look: Six-Month 2026 US Property/Casualty Financial Results,” and the data is derived from companies’ six-month 2026 interim period statutory statements...
-
Soluna Finishes Kati 1 and Secures Conditional Base Load Position for All 166 MW in ERCOT
ALBANY, N.Y.--(BUSINESS WIRE)--Soluna Holdings, Inc. ("Soluna" or the "Company") (NASDAQ: SLNH), a developer of green data centers for intensive computing applications, including AI and Bitcoin mining, today announced two milestones at its Project Kati campus in Willacy County, Texas. The Company has energized the final 14 MW at Project Kati 1, completing the 83 MW site, and has been notified that ERCOT has conditionally classified the full 166 MW Kati campus, including the planned Kati 2 AI ex...
-
IonQ Announces Increased Full-Year 2026 Financial Outlook Following SkyWater Acquisition
COLLEGE PARK, Md.--(BUSINESS WIRE)--IonQ (NYSE: IONQ), the world’s leading full-stack quantum platform and foundry, today announced that, for the full year 2026, it expects revenue to be between $450 million and $460 million. This outlook includes the contributions of SkyWater Technology beginning on July 31, 2026, the date it was acquired by IonQ, through to Dec. 31, 2026. It also reflects elimination of estimated intercompany revenues under the pre-existing commercial agreement between IonQ an...
-
AEVEX Completes Acquisition of BlackSea Technologies, Creating One of the Defense Industry’s Most Capable Multi‑Domain Autonomous Systems Providers
SOLANA BEACH, Calif.--(BUSINESS WIRE)--AEVEX Corp. (NYSE: AVEX), a leading U.S. defense technology company delivering autonomous unmanned systems, AI‑enabled mission software, and advanced ISR and electronic warfare solutions, today announced the closing of its acquisition of BlackSea Technologies (“BlackSea”), one of the largest providers of unmanned surface and subsea vessels in the U.S. defense market. Following the closing, BlackSea becomes AEVEX’s Maritime Systems division, led by former B...
-
Canopy Growth Broadens Australian Medical Cannabis Portfolio With New Formats and Formulations
SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth”, “our”, “we” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a leading global company committed to bettering lives through cannabis, today announced a broadening of its medical cannabis portfolio in Australia across its Spectrum Therapeutics, Spectrum Therapeutics Reserve, 7ACRES, Tweed and Twd. brands. The expansion introduces two new product formats, and new formulations within its existing oil and softgel ranges....